Global Biotech News
Featured Story
As GLP-1 demand explodes globally, China is rapidly becoming one of the world’s most important peptide manufacturing hubs.
2026-05-28
As global demand for GLP-1 therapies surges, the peptide API industry is rapidly transitioning from small-scale synthesis to industrialized manufacturing.
2026-05-21
China’s biopharmaceutical industry is entering a new phase driven by policy reform, innovation, and global expansion.
2026-05-20
China’s innovative drugs sector is accelerating global collaboration through policy support, clinical progress, and expanding outbound licensing activity.
2026-05-29
As GLP-1 demand explodes globally, China is rapidly becoming one of the world’s most important peptide manufacturing hubs.
Continue Reading →
2026-05-28
As global demand for GLP-1 therapies surges, the peptide API industry is rapidly transitioning from small-scale synthesis to industrialized manufacturing.
Continue Reading →
2026-05-21
China’s biopharmaceutical industry is entering a new phase driven by policy reform, innovation, and global expansion.
Continue Reading →
2026-05-20
China’s innovative drugs sector is accelerating global collaboration through policy support, clinical progress, and expanding outbound licensing activity.
Continue Reading →